<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource<break/></th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Antibody</td><td valign="top">anti-human CD3 PE/Cy7 <break/>(mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:300316</td><td valign="top">FACS (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD4 APC <break/>(rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:357408</td><td valign="top">FACS (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD8a FITC (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:301050</td><td valign="top">FACS (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-human CD11c FITC (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:301604</td><td valign="top">FACS (1:50)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-human Fc&#947;RIIb PE (recombinant human IgG1-N297A)</td><td valign="top">in house</td><td valign="top">Clone 2B6</td><td valign="top">FACS (1:50)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD19 Brilliant Violet 510 <break/>(mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:302242</td><td valign="top">FACS (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD20 FITC (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:302304</td><td valign="top">FACS (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD33 PE (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:303404</td><td valign="top">FACS (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD33 BV510 (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:303422</td><td valign="top">FACS (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD45 APC/Fire750 (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:304062</td><td valign="top">FACS (1:400)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD69 PerCP/Cy5.5 (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:310926</td><td valign="top">FACS (1:100)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-human CD138 PE/Cy7 (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:356514</td><td valign="top">FACS (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-mouse/human CD11b PerCP/Cy5.5 (rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:101228</td><td valign="top">FACS (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-mouse CD45.1 PE (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:110707</td><td valign="top">FACS (1:600)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-mouse CD45.1 Brilliant Violet 421 (mouse monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:110732</td><td valign="top">FACS (1:400)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-mouse CD62L PE/Cy7 (rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:104418</td><td valign="top">FACS (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-mouse F4/80 APC/Fire 750 (rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:123152</td><td valign="top">FACS (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-mouse Gr-1 Brilliant Violet 510 (rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:108437</td><td valign="top">FACS (1:300)</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-mouse Ly-6G FITC (rat monoclonal)</td><td valign="top">BioLegend</td><td valign="top">Cat.#:127606</td><td valign="top">FACS (1:300)</td></tr><tr><td valign="top">Antibody</td><td valign="top">9E9 Alexa647 (rabbit monoclonal)</td><td valign="top"><xref ref-type="bibr" rid="bib35">Nimmerjahn et al., 2005</xref> <break/></td><td valign="top">n/a</td><td valign="top">FACS (1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-human CD4 (for depletion) (mouse monoclonal)</td><td valign="top">BioXCell</td><td valign="top">Cat.#:BE0003-2</td><td valign="top">100 &#181;g per injection</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-human CD20 (for depletion) (recombinant mouse monoclonal)</td><td valign="top"><xref ref-type="bibr" rid="bib20">Kao et al., 2015</xref></td><td valign="top">In house</td><td valign="top">25 &#181;g per injection</td></tr><tr><td valign="top">Strain, strain background <italic>Mus musculus</italic></td><td valign="top">NOD.Cg-Prkdc&lt;scid&#160;&gt;&#160;Il2rg<sup>tm1Wjl/Szj</sup></td><td valign="top">The Jackson Laboratory</td><td valign="top">Cat.#:005557</td><td valign="top">n/a</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Graph Pad Prism 7.03</td><td valign="top">GraphPad Software Inc, San Diego, CA, USA</td><td valign="top"/><td valign="top"/></tr></tbody></table></table-wrap>